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Abstract. The CloudUPDRS app has been developed as a Class I med-
ical device to assess the severity of motor symptoms for Parkinson’s
Disease using a fully automated data capture and signal analysis pro-
cess based on the standard Unified Parkinson’s Disease Rating Scale. In
this paper we report on the design and development of the signal pro-
cessing and longitudinal data analytics microservices developed to carry
out these assessments and to forecast the long-term development of the
disease. We also report on early findings from the application of these
techniques in the wild with a cohort of early adopters.
1 Introduction
The CloudUPDRS app and its associated information management and ana-
lytics platform, have been designed and developed to meet the standards set
for medical devices. CloudUPDRS achieves the accurate, precise, and repeat-
able assessment of motor symptoms for people with Parkinson’s (PwP), which
clinicians can use with confidence. The app itself is employed as a data capture
device relaying captured information to a service back-end developed following
the microservices pattern [4] incorporating a so-called signal processing service
that converts raw observations to motor performance metrics and a data an-
alytics service that carries out longitudinal analyses revealing the pattern of
development of the disease over time.
CloudUPDRS capitalises on the observation that it is possible to employ cer-
tain aspects of movement that are disrupted in Parkinson’s as surrogate biomark-
ers of dopamine levels, a fact that forms the basis for Part III of the mds-updrs.
Previously, we investigated the possibility to precisely quantify and implement
the mds-updrs methodology as a smartphone app to enable the assessment of
motor performance through tremor, gait and bradykinesia measurements ob-
tained from standard sensors embedded in smartphones within a clinical setting
[2]. Extending this approach, we currently focus on capturing in-depth medical
intelligence supporting the discovery of longitudinal trends, promoting deeper
understanding of the patterns of normal daily symptom variations, and predict-
ing the onset of dyskinesias thus facilitating high-precision personalised targeting
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Fig. 1. Correlation between CloudUPDRS metrics and the corresponding sections of
mds-updrs.
of treatment. A key ingredient of this work is that we have successfully trans-
ferred the process that until recently was available only in the clinical setting so
that PwP and their carers can administer the tests unsupervised at home. We an-
ticipate a significant reduction of the number of emergency hospital visits while
considerably increasing data availability through high-frequency assessment of a
large population of PwP.
2 The CloudUPDRS app and Service Platfrom
Overall, the CloudUPDRS system consists of the following elements:
1. PD patient smartphone apps for Android and iOS that carry out motor per-
formance measurements and wellness self-assessment; conduct session man-
agement; securely transfer captured data to the CloudUPDRS service; and,
present an interface providing guidance and feedback.
2. Cloud-based scalable data collection engine that safely and securely collects
data from patients’ smartphones; ensures secure data management; and ap-
plies the mds-updrs signal processing pipeline.
3. A data analytics toolkit for medical intelligence incorporating quantitative
and semi-structured data, and longitudinal analyses, clustering and classifi-
cation; and a clinical user interface incorporating visualisation.
The CloudUPDRS service platform enables the secure capture, management
and analysis of data collected by the app and provides effective communication of
insights generated to clinicians enabling them to explore alternative treatment
scenarios. To cater for the diverse needs of the PwP population in the UK,
the platform has been engineered to facilitate scalable performance by adopting
the microservices architecture [6]. The microservices architectural style is set
in contrast to traditional monolithic web applications and aims to maximise
opportunities for vertical decomposition and scaling-out, which are critical for
high performance and service resilience in data intensive situations.
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Fig. 2. Individual patient longitudinal analysis of kinetic tremor of the left hand and
left leg agility showing significant daily variations.
3 Signal Processing Toolkit
Standard practice in conducting assessments of the severity of PD symptoms
involves visit to a clinic and the use of clinical rating scales such as the mds-
updrs [1], using patient diaries or other self-completed scales. Nevertheless, it
is possible to perform more precise objective assessment of tremor, bradykinesia
and gait using laboratory equipment and closely tracing Part III of the mds-
updrs protocol. Indeed, this is common practice when detailed and accurate
information is required for example when researching the effectiveness of new
treatments. Such laboratory equipment typically includes specialised biomedical
data acquisition systems incorporating transducers such as high-frequency/high-
accuracy accelerometers and gyroscopes, signal amplifiers and filters and high-
performance analog-to-digital converters as well as advanced single processing
software. These systems are obtained by specialist commercial providers such as
Cambridge Electronic Design Ltd in the UK, currently the market leader, with
the total cost of a complete system rising to tens of thousands.
3.1 Tremor
Tremor measurements are recorded for both hands at rest, at posture and in
action. For rest tremor measurements, users are asked to relax their hands on
their lap in a supine position while the phone is lying in their palm. For the
postural tremor measurements patients are guided to keep their arm outstretched
directly at their front while holding the smartphone. Finally, for action tremor
measurements they are required to hold the phone and move it between the
chest and the fully outstretched position at their front. In all cases, acceleration
is recorded along three axes in m/s2 at the maximum supported sampling rate
and timestamped at maximum resolution (typically microseconds).
Tremor is calculated as the cumulative magnitude of the scalar sum acceler-
ation across three axes for all frequencies between 2Hz to 10Hz. To obtain this
power spectrum the signal is first filtered with a Butterworth high-pass second
order filter at 2Hz and the Fast Fourier Transform (FFT) subsequently applied
to the filtered waveform data.
4 G. Roussos et al.
3.2 Bradykinesia
Mds-updrs assess bradykinesia, or else the slowness of movement, through three
different factors: (i) pronation-supination movements, (ii) leg agility, and (iii)
finger tapping. In the first test patients are asked to hold the phone and perform
alternating pronation-supination movements, that is rotating the palm of the
hand toward the inside so that it is facing downward and then toward the outside
so that the palm is facing upward, as fast and as fully as possible. Leg agility
measurements require the phone to be placed on the thigh of the patient while
seated, holding the phone lightly with the ipsilateral hand, while raising and
stomping the foot on the ground as high and as fast as possible. During both
tests the phone is recording acceleration data in a manner similar to the tremor
tests.
The assessment of the pronation-supination movements and leg agility tests
requires the estimation of the frequency and power of movement. To obtain
these, the toolkit first removes DC and applies a Butterworth low-pass second
order filter at 4Hz in order to exclude most of the tremor. Subsequently, the
power of the movement is calculated as the total amplitude between 0Hz and
4Hz and the frequency derived from the power spectrum.
Finger tapping performance is assessed in two tests using single and dual
targets presented on the screen of the phone at set locations with patients at-
tempting to tap them as fast and as accurately as possible (alternating between
targets in the dual-target case). When tapping accidentally occurs outside the
screen area the test is repeated. The touch-sensitive screen of the smartphone
is used to collect the information used for performance calculations, specifically
the timing of each touch event, its duration, the direction of movement (upwards
or downwards), the coordinates on the phone screen, and the amount of pressure
applied are recorded. For the two-target variant it is necessary that the distance
between targets be at a specific distance irrespective of the size of the screen or
of the device.
To estimate finger tapping performance the analytical functions first iden-
tify all touch events and employ the associated timestamps to estimate tap
frequency (expressed as number of taps per second), the mean hand movement
time between taps (in milliseconds), and the actual movement distance between
alternative tappings in the dual-target case (in centimetres). The calculation of
distance requires scaling of measurements expressed in screen pixels to account
for the pixel density characteristics of to particular smartphone model. Similar
to tremor, bradykinesia functionalities in the CloudUPDRS analytics toolkit are
implemented in python incorporating features from NumPy and SciPy.
3.3 Gait
Mds-updrs assesses gait by considering multiple behaviours including stride
amplitude and speed, height of foot lift and heel strike, and turning and arm
swing. The CloudUPDRS variant of this test requires the patient to walk along
a straight line for five meters, turn around and return to the point of departure,
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Fig. 3. Patterns of daily variation during a typical day of bradykinesia symptoms. The
graph on the right displays a smoothed curve representing fine grain progression and
offers a measure of variation between days.
while the smartphone is positioned either in their belt or trousers pocket. Since it
is only possible to measure acceleration data from a single point at the waistline
it is realistic to attempt the estimation of only stride frequency and length, ve-
locity and turning time. The estimation of these measurements in CloudUPDRS
follows the techniques suggested [3] using PyWavelets for their implementation
in python.
4 Testing
The performance of the CloudUPDRS signal processing toolkit was validated
on a bespoke data set comprised of 20 complete sets of measurements. Results
obtained from its application were compared against the same calculations im-
plemented using Spike2 and matlab and compared against the UPDRS score
provided for each test and patient by an experienced clinician after carrying out
their standard assessment during a hospital consultation. This study [2] con-
firmed the consistent performance of CloudUPDRS against the golden standard
i.e. clinical result and indeed indicated consistent accuracy exceeding 10−3 rela-
tive error suffices for mds-updrs assessment.
5 Longitudinal Data Analytics
Having established the capability to conduct motor performance assessments at
home and in the community using the CloudUPDRS app we have now developed
a community of early adopters to develop and test a data analytics framework
to study the longer-term development of the disease. Of particular interest is
the investigation of ways to cluster patients in smaller groups that have similar
progression patterns and are responsive to similar treatment. Indeed, symp-
toms vary greatly independent of treatment and PD progresses at different rates
in different individuals, it requires regular clinical monitoring and medication
adjustment. Our specific aim to develop novel opportunities to precisely quan-
tify PD progression and the effectiveness of patient stratification [5]: the wider
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availability of data concerning individual variability and actual symptom trends
provided by CloudUPDRS is expected to identify opportunities to adapt care to
the needs of a particular individual at a specific time.
The first stage of this work is the identification of daily, weekly and longer
patterns of variation in symptoms which would provide the baseline for adap-
tation. Figure 2 shows how upper and lower body performance varies during a
period of weeks – clearly the day-to-day variation is significant and more impor-
tantly this variation is not typically captured by UPDRS scores that smooth out
differences. Further, Figure 3 shows an aggregate pattern of performance varia-
tion for bradykinesia thus providing an early result towards the development of
characteristic patterns of disease variation for the individual.
6 Work in Progress
The longitudinal analysis presented in the previous Section has been based on
data collected during a period of four months and while further improvements
were implemented in both analytics and app. In particular, we are now able to
identify a subset of tests that are specifically selected for each patient matching
their particular symptoms. This allows a considerable reduction in the time re-
quired to carry out the test thus allowing even more more frequent assessments.
We anticipate that in the coming six month period we will have collected ad-
equate information to be able to create progression profiles and in particular
conduct reliable trend analysis on individual performance. This will further en-
able experimentation with clustering and classification techniques towards our
objective of patient stratification.
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